Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997-2007

Estoppey, Daniel; Paccaud, Fred; Vollenweider, Péter; Marques‐Vidal, Pedro

doi:10.1186/1471-2458-11-114

Cited by 51 publications

(47 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It should also be noted that the incidence of pre-existing hypertension was high (34%) in this population of 169 patients. In 2007, the prevalence of hypertension was 24.1% in Swiss adults [10]; however, in this study, the hypertension was self-reported and a predominantly healthy population was evaluated [11]. It is possibly that in a seriously ill patient population, such as those studied here, there might be ‘negative selection' of patients with a higher incidence of arterial hypertension.…”

Section: Discussionmentioning

confidence: 99%

Pre-Existing Antihypertensive Treatment Predicts Early Increase in Blood Pressure during Bevacizumab Therapy: The Prospective AVALUE Cohort Study

Wicki

Hermann²,

Prêtre³

et al. 2014

Oncol Res Treat

View full text Add to dashboard Cite

Background: Antiangiogenic therapy is routinely used in a variety of cancer entities. Hypertension is the most common side effect of all currently available antiangiogenic treatments. Patients and Methods: In this prospective observational clinical trial, we investigated risk factors for blood pressure elevation in patients exposed to an antiangiogenic agent and explored the correlation between hypertension and the duration of antiangiogenic treatment. Results: In 169 patients, pre-existing antihypertensive medication was the most prominent risk factor associated with increased blood pressure during therapy. Between visits 1 and 3, the median systolic blood pressure increased by 10.85 mmHg in patients with pre-existing hypertension receiving antihypertensive medication while it increased by only 2.69 mmHg in patients without hypertension. The median increase in diastolic pressure was 7.28 versus 0.11 mmHg in patients with versus without pre-existing hypertension. Increases in blood pressure occurred early (within 6 weeks of starting therapy). In spite of this significant increase in the blood pressure, no major bleeding events or other related complications were observed during antiangiogenic therapy. Conclusions: Pre-existing hypertension and treatment with antihypertensive medication correlated with a more pronounced increase in blood pressure. Thus, intensified antihypertensive therapy might be warranted early during bevacizumab therapy in patients already receiving antihypertensive treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

Pre-Existing Antihypertensive Treatment Predicts Early Increase in Blood Pressure during Bevacizumab Therapy: The Prospective AVALUE Cohort Study

Wicki

Hermann²,

Prêtre³

et al. 2014

Oncol Res Treat

View full text Add to dashboard Cite

show abstract

“…However, the variation in definition of age brackets hinders any direct comparison between studies. In Switzerland, the prevalence of self-reported arterial hypertension in individuals 15 years or older increased from 22.1% to 24.2% in a 10-year period 12 . In the United States, self-reported arterial hypertension among individuals 18 years of age and older increased from 68.5% to 80.6% between 1988 and 2008 9,10,11 .…”

Section: Discussionmentioning

confidence: 99%

“…In Brazil, the Telephone Survey for Surveillance of Risk and Protective Factors for Chronic Non-Communicable Diseases (VIGITEL) showed that self-reported arterial hypertension increased evenly and significantly in the 27 State capitals included in the study, varying from 21.5% to 24.4% from 2006 to 2009 7 . Developed countries like Switzerland, Canada, and the United States have also shown increases in the prevalence of self-reported arterial hypertension 8,9,10,11,12 .…”

Section: Introductionmentioning

confidence: 99%

Trends in self-reported arterial hypertension in Brazilian adults: an analysis of data from the Brazilian National Household Sample Survey, 1998-2008

et al. 2012

View full text Add to dashboard Cite

This study investigated the time trend in selfreported arterial hypertension from 1998 to 2008 in individuals older than 20 years in Brazil. Data were analyzed on prevalence of hypertension from the National Household Sample Survey (PNAD) for the years 1998, 2003, and 2008. The analysis considered the sampling complexity and included 203,419, 238,591, and 257,816 individuals in the years 1998, 2003, and 2008, respectively. The time trend in hypertension was analyzed by sex, family income, geographic regions of Brazil, and area of residence (urban versus rural), and the prevalence rates were adjusted for age. Prevalence of self-reported hypertension was 12.5% in 1998, 13% in 2003, and 13.9% in 2008, with

show abstract

“…In Switzerland, CVD mortality has dramatically decreased over the past three decades resulting in internationally very low rates (8). Counterintuitively, this apparently occurred without antecedent decrease in CVD-RF (10)(11)(12). We aimed at determining the impact of four traditional CVD-RF on CVD mortality in Switzerland and their population burden in terms of PAR and survival.…”

mentioning

confidence: 99%

Public health significance of four cardiovascular risk factors assessed 25 years ago in a low prevalence country

Faeh

Braun

Tarnutzer

et al. 2011

Eur J Prev Cardiolog

View full text Add to dashboard Cite

Background: The individual and combined effect of cardiovascular disease (CVD) risk factors (RFs) on CVD mortality varies between populations. Our aim was to examine this association and its public health impact in Switzerland, a country with comparably low CVD mortality. Methods: We included 9853 men and women aged 25-74 years who participated in the Swiss MONICA (MONItoring of trends and determinants in CArdiovscular disease) study (1983)(1984)(1985)(1986)(1987)(1988)(1989)(1990)(1991)(1992) and were followed up for survival until 2008. Adjusted Cox regression was used to calculate CVD mortality hazard ratios (HR). CVDRFs were obesity (body mass index 30 kg/m(2)), smoking (1 cig/d), high blood pressure (140 or 90 mmHg), and total: high-density lipoprotein cholesterol ratio (5.0). Besides age and sex, models were adjusted for diet, physical activity, educational class, marital status, and the respective other CVD-RFs. Results: After adjustment for age and sex, the HR of CVD death was for obesity 1.86 (95% CI 1.50-2.31), for smoking 1.63 (95% CI 1.32-2.01), for high blood pressure 1.42 (95% CI 1.16-1.73), and for high cholesterol ratio 1.30 (95% CI 1.06-1.60). Adjustment for other covariates moderately attenuated estimates. CVD-RFs had an independent and synergistic effect and accounted for 43.0% of population attributable risk. The presence of all four compared to zero CVD-RFs was associated with a 9.6 years shorter expected survival for a man aged 50. Conclusions: Most CVD deaths could be avoided by prevention of four traditional CVD-RFs. Reduction of smoking prevalence and avoidance of weight gain in the population are the most effective measures. Particular attention should be dedicated to persons with multiple CVD-RFs. BackgroundThe individual and combined effect of cardiovascular disease (CVD) risk factors (RF) on CVD mortality varies between populations. Our aim was to examine this association and its public health impact in Switzerland, a country with comparably low CVD mortality.

show abstract

Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997-2007

Cited by 51 publications

References 36 publications

Pre-Existing Antihypertensive Treatment Predicts Early Increase in Blood Pressure during Bevacizumab Therapy: The Prospective AVALUE Cohort Study

Pre-Existing Antihypertensive Treatment Predicts Early Increase in Blood Pressure during Bevacizumab Therapy: The Prospective AVALUE Cohort Study

Trends in self-reported arterial hypertension in Brazilian adults: an analysis of data from the Brazilian National Household Sample Survey, 1998-2008

Public health significance of four cardiovascular risk factors assessed 25 years ago in a low prevalence country

Contact Info

Product

Resources

About